ID: ALA4781451

Max Phase: Preclinical

Molecular Formula: C57H80N8O14S2

Molecular Weight: 1165.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)C(C)C)cc1

Standard InChI:  InChI=1S/C57H80N8O14S2/c1-36(2)49(55(72)64-30-43(66)26-45(64)53(70)58-28-39-8-12-41(13-9-39)50-37(3)60-34-80-50)62-47(68)32-78-24-22-76-20-18-74-16-17-75-19-21-77-23-25-79-33-48(69)63-52(57(5,6)7)56(73)65-31-44(67)27-46(65)54(71)59-29-40-10-14-42(15-11-40)51-38(4)61-35-81-51/h8-15,34-36,43-46,49,52,66-67H,16-33H2,1-7H3,(H,58,70)(H,59,71)(H,62,68)(H,63,69)/t43-,44-,45+,46+,49+,52-/m1/s1

Standard InChI Key:  MYKUZIAADLKQLR-ZVOHJLPKSA-N

Associated Targets(Human)

VHL/Cereblon 225 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1165.44Molecular Weight (Monoisotopic): 1164.5235AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Girardini M,Maniaci C,Hughes SJ,Testa A,Ciulli A.  (2019)  Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.,  27  (12.0): [PMID:30826187] [10.1016/j.bmc.2019.02.048]

Source